[{"Assets_0_Q1_USD":667668000.0,"CommonStockSharesOutstanding_0_Q1_shares":41438020.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-20492000.0,"NetIncomeLoss_1_Q1_USD":-40977000.0,"StockholdersEquity_0_Q1_USD":285711000.0,"Ticker":"TVTX","CIK":"1438533","name":"RETROPHIN, INC.","OfficialName":"Travere Therapeutics Inc. Common Stock","form":"10-Q","period":"20190331","fy":"2019.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1905907401.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20190507"}]